ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,000.00
1.77%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nymox Pharmaceutical Corp (NYMX)

  7. Nymox Pharmaceutical Corp (NYMX) Noticias

NYMX

Nymox Pharmaceutical (NYMX)

Nymox Pharmaceutical Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NYMX
FechaHoraFuenteTítuloSímboloCompañía
28/03/202412:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
08/09/202309:13Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NYMXNymox Pharmaceutical Corp
25/07/202309:33GlobeNewswire Inc.Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial ResultsNASDAQ:NYMXNymox Pharmaceutical Corp
18/07/202309:45GlobeNewswire Inc.Nymox Reports on U.S. Patent IssuancesNASDAQ:NYMXNymox Pharmaceutical Corp
13/07/202309:16GlobeNewswire Inc.Nymox UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
12/07/202308:30GlobeNewswire Inc.Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of NymoxNASDAQ:NYMXNymox Pharmaceutical Corp
07/07/202316:02GlobeNewswire Inc.NYMOX UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
05/07/202317:11GlobeNewswire Inc.Nymox Delisting from NASDAQNASDAQ:NYMXNymox Pharmaceutical Corp
29/06/202316:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NYMXNymox Pharmaceutical Corp
29/06/202315:25Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:NYMXNymox Pharmaceutical Corp
29/06/202315:24Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:NYMXNymox Pharmaceutical Corp
26/06/202309:28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NYMXNymox Pharmaceutical Corp
10/05/202309:00GlobeNewswire Inc.Nymox Provides Current UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
03/04/202308:30GlobeNewswire Inc.Nymox Provides Corporate UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
31/03/202315:25Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:NYMXNymox Pharmaceutical Corp
21/03/202309:00GlobeNewswire Inc.Nymox Announces Appointment of Christopher R. Riley as Chief Financial OfficerNASDAQ:NYMXNymox Pharmaceutical Corp
15/03/202308:30GlobeNewswire Inc.Nymox Officially Granted Extension to Regain Listing RequirementsNASDAQ:NYMXNymox Pharmaceutical Corp
15/02/202310:50GlobeNewswire Inc.Nymox Announces NYMOZARFEX Marketing Application is Accepted For ReviewNASDAQ:NYMXNymox Pharmaceutical Corp
06/01/202315:30GlobeNewswire Inc.NYMOX Appeals Deficiency LetterNASDAQ:NYMXNymox Pharmaceutical Corp
05/12/202208:30GlobeNewswire Inc.NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPHNASDAQ:NYMXNymox Pharmaceutical Corp
25/11/202214:10GlobeNewswire Inc.May 2023 Market Cap Requirement UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
13/09/202208:30GlobeNewswire Inc.NYMOX Provides Current UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
15/07/202208:30GlobeNewswire Inc.NYMOX Updates ShareholdersNASDAQ:NYMXNymox Pharmaceutical Corp
14/07/202211:18GlobeNewswire Inc.NYMOX Receives Deficiency Letter from NASDAQNASDAQ:NYMXNymox Pharmaceutical Corp
23/05/202207:30GlobeNewswire Inc.NYMOX Receives RTF letter from FDANASDAQ:NYMXNymox Pharmaceutical Corp
06/05/202205:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NYMXNymox Pharmaceutical Corp
13/04/202205:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NYMXNymox Pharmaceutical Corp
04/04/202208:45GlobeNewswire Inc.Nymox Announces Closing of $6.4 Million FinancingNASDAQ:NYMXNymox Pharmaceutical Corp
22/03/202213:57Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NYMXNymox Pharmaceutical Corp
18/03/202207:30GlobeNewswire Inc.Nymox Announces $5 Million Registered Direct OfferingNASDAQ:NYMXNymox Pharmaceutical Corp
 Showing the most relevant articles for your search:NASDAQ:NYMX

Su Consulta Reciente

AMEX
XLV
Health Care Select Sector
CCOM
US30
US 30
NYSE
AXP
American Express
NYSE
CVX
Chevron
COIN
ETHUSD
Ethereum
CCOM
US500
US 500
NYSE
VZ
Verizon Communications
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
NYSE
BAC
Bank of America
NASDAQ
TSLA
Tesla
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados